Key result
Cardiovascular disease causes ~33% of UK deaths, underscoring the urgent need for primary prevention.
Why the study?
Cardiovascular disease is an increasing major cause of morbidity and mortality globally, and guidelines vary in approaches to primary prevention strategies such as hypertension management and lipid optimization.
Primary prevention through lifestyle changes and risk factor management is crucial to reducing the growing global burden of cardiovascular disease.
Does not alter practice; leaves open optimal prevention implementation in high-burden regions.
AbstractIn the United Kingdom, cardiovascular disease is a major and increasing issue, accounting for almost one-third of all fatalities and causing considerable morbidity. It is also of special and urgent importance as emerging nations undergo lifestyle changes that bring new risk factors for cardiovascular disease, resulting in an increase in cardiovascular disease risk throughout the developing globe. Because the burden of cardiovascular disease may be reduced via deliberate risk reduction, primary prevention should be a top goal for all health policymakers. International recommendations agree on the significance of quitting smoking, losing weight, and exercising, however guidelines differ somewhat in their approach to hypertension and significantly in their approach to achieving an optimum lipid profile, which remains a controversial topic. Although formerly popular concepts like the polypill seem to be empty of in-vivo effectiveness, there are still areas of potential interest, such as the advantage of lowering serum urate and the utility of lowering homocysteine levels.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2021) conducted a review in Cardiovascular disease. Primary prevention of cardiovascular disease requires deliberate risk reduction, although international guidelines differ significantly in their approaches to hypertension and optimal lipid profiles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: